FDA inspection

Bristol-Myers Squibb Manufacturing Company Unlimited Company: FDA inspection ending May 16, 2001

FDA inspection 74449 · Voluntary Action Indicated (VAI) · Humacao, PR

Key facts

Inspection ID 74449
Firm Bristol-Myers Squibb Manufacturing Company Unlimited Company
FEI number 2623458
Address State Rd #3 Km 77.5
City Humacao
State PR
ZIP 00791
Fiscal year 2001
Inspection end date May 16, 2001
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections